Catalyst Wire Dossier Catalyst Wire Dossier

Aggrenox (Aspirin + extended-release dipyridamole)

Aspirin and dipyridamole combination (extended-release) · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aggrenox (Aspirin + extended-release dipyridamole), covering 2009-09-02 to 2009-09-02. Get the full timeline:

Most recent: Clinical Trial Update: PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes [Phase 4]

See pricing